¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"facial atrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • villous atrophy
    À¶¸ðÀ§Ãà
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • steroid-induced atrophy
    ½ºÅ×·ÎÀ̵åÀ§Ãà
  • subcutaneous atrophy
    ÇÇÇÏÀ§Ãà, ÇǺιØÀ§Ãà
  • toxic atrophy
    Áßµ¶À§Ãà
  • villous atrophy
    À¶¸ðÀ§Ãà
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • facial vein
    ¾ó±¼Á¤¸Æ
  • familial focal facial dermal dysplasia
    °¡Á·¼º ±¹¼Ò ¾È¸é ÁøÇÇ ÀÌÇü¼º
  • female facial melanosis
    ¿©¼º ¾È¸éÈæÇÇÁõ
  • geniculum of facial canal
    ¾ó±¼½Å°æ°ü¹«¸­
  • genu (of facial nerve)
    (¾ó±¼½Å°æ)¹«¸­
  • hiatus of facial canal
    Å«¹ÙÀ§½Å°æ°üÆ´»õ
  • horizontal facial cleft
    ¼öÆò¾È¿­(¡­äÔæñ).
  • hypomelia-hypotrichosis-facial haemangioma syndrome
    ´ÜÁö-ºó¸ð-¾È¸é Ç÷°üÁ¾ ÁõÈıº
  • idiopathic facial paralysis
    Ư¹ß¼º ¾È¸é½Å°æ¸¶ºñ.
  • idiopathic facial paralysis
    Ư¹ß¼º ¾È¸é½Å°æ¸¶ºñ
  • internal genu of facial nerve
    ¾ó±¼½Å°æ¼Ó¹«¸­
  • median facial cleft
    Á¤Á߾ȸ鿭(ïáñéäÔØüæñ).
  • nerve decompression, facial
    ¾È¸é½Å°æ°¨¾Ð¼ú
  • nerve of pterygoid canal [facial root]
    ³¯°³°ü½Å°æ (¾ó±¼½Å°æ»Ñ¸®)
  • nerve paralysis, facial
    ¾È¸é½Å°æ¸¶ºñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
DIDMOA diabetes insipidus-diabetes mellitus-optic atrophy [syndrome]
DIDMOAD diabetis insipidus, diabetes mellitus, otpic atrophy, deafness [syndrome]
DIMOAD diabetes insipidus, diabetes mellitus, optic atrophy, deafness
DJOA dominant juvenile optic atrophy
DMOA diabetes mellitus-optic atrophy [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
SMA SPINAL muscular atrophy
SBMA Spinal and bulbar muscular atrophy
LCCA late cortical cerebellar atrophy
PMA progressive muscular atrophy
VA villous atrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • facial nerve block
    ¾È¸é ½Å°æ Â÷´Ü
  • facial nerve palsy
    ¾È¸é ½Å°æ ¸¶ºñ
  • facial neuralgia
    ¾È¸é ½Å°æÅë
  • facial pain
    ¾È¸é ÅëÁõ, ¾È¸é µ¿Åë, ¾È¸éÅë
    Ä¡°ú Àǻ翡°Ô ¾È¸é µ¿ÅëÀÇ Áø´ÜÀº ¸Å¿ì ¾î·Á¿î ÀÏÀÌ´Ù. ¾È¸éºÎ µ¿ÅëÀÇ ¼º°øÀû Áø´ÜÀº Á¤È®Çϰí ÀÚ¼¼ÇÑ µ¿ÅëÀÇ º´·Â°ú ¾È¸é°ú ¿¬°üºÎÀÇ ÀÚ¼¼ÇÑ ÀÓ»óÀû °Ë»ç ¹× ¾È¸é µ¿ÅëÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â Á¶°Ç¿¡ ´ëÇÑ ÇØ¹ÚÇÑ Áö½Ä¿¡ ´Þ·Á ÀÖ´Ù. ±¸°­°ú ¾È¸éÀÇ µ¿ÅëÀº Ä¡¼ºÀÏ ¼öµµ ÀÖ°í ¶Ç´Â ºñÄ¡¼ºÀÏ ¼öµµ ÀÖ´Ù. ºÒÇÊ¿äÇÑ ¹ßÄ¡¸¦ ÇÏÁö ¾Ê±â À§Çؼ­ Á¤È®ÇÑ Áø´ÜÀ» ÇØ¾ß ÇÑ´Ù.
  • facial pain of unknown origin
    ¿øÀÎ ºÒ¸íÀÇ ¾È¸é ÅëÁõ, Àڹ߼º ¾È¸é ÅëÁõ
  • facial paralysis
    ¾È¸é ¸¶ºñ, ¾È¸é½Å°æ ¸¶ºñ
    Bell ¸¶ºñó·³ ¾È¸é ½Å°æ ±â´ÉÀÇ ÀúÇÏ ¶Ç´Â ¸¶ºñ.
  • facial plane
    ¾È¸é Æò¸é
  • facial process
    ¾È¸é µ¹±â
  • facial prosthesis
    ¾È¸é º¸Ã¶¹°
  • facial protector
    ¾È¸é º¸È£±â, ¾È¸é ½Å°æ º¸È£±â
  • facial reflex
    ¾È¸é±Ù ¹Ý»ç
  • facial skull
    ¾È¸é °ñ°Ý
  • facial symmetry
    ¾È¸é ´ëμº
  • facial tic
    ¾È¸é °æ·Ã
    ¾È¸éÀÇ ¸ðµç °æ·Ã¼º ¿îµ¿À̳ª ¿¬Ãà.
  • facial vein
    ¾ó±¼ Á¤¸Æ, ¾È¸é Á¤¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
infantile muscular atrophy Transmitted as autosomal recessive on chromosome 5q. Progressive dysfunction of the anterior horn cells in the spinal cord and brainstem cranial nerves with profound weakness and bulbar dysfunction occurring in the first two years of life. Three groups, based on age of clinical onset, are recognised.
Synonym: familial spinal muscular atrophy, Hoffmann's muscular atrophy, infantile muscular atrophy, infantile progressive spinal muscular atrophy, progressive infantile spinal muscular atrophy, Werdnig-Hoffmann disease, Werdnig-Hoffmann muscular atrophy.
(05 Mar 2000)
infantile progressive spinal muscular atrophy Transmitted as autosomal recessive on chromosome 5q. Progressive dysfunction of the anterior horn cells in the spinal cord and brainstem cranial nerves with profound weakness and bulbar dysfunction occurring in the first two years of life. Three groups, based on age of clinical onset, are recognised.
Synonym: familial spinal muscular atrophy, Hoffmann's muscular atrophy, infantile muscular atrophy, infantile progressive spinal muscular atrophy, progressive infantile spinal muscular atrophy, Werdnig-Hoffmann disease, Werdnig-Hoffmann muscular atrophy.
(05 Mar 2000)
infantile spinal muscular atrophy Transmitted as autosomal recessive on chromosome 5q. Progressive dysfunction of the anterior horn cells in the spinal cord and brainstem cranial nerves with profound weakness and bulbar dysfunction occurring in the first two years of life. Three groups, based on age of clinical onset, are recognised.
Synonym: familial spinal muscular atrophy, Hoffmann's muscular atrophy, infantile muscular atrophy, infantile progressive spinal muscular atrophy, progressive infantile spinal muscular atrophy, Werdnig-Hoffmann disease, Werdnig-Hoffmann muscular atrophy.
(05 Mar 2000)
ischemic muscular atrophy See: Volkmann's contracture.
(05 Mar 2000)
olivopontocerebellar atrophy A collection of diseases with atrophy of the cerebellum, pons, and inferior olives described in 1900 by dejerine and thomas. Signs and symptoms include ataxia of trunk and limbs, dysarthria, intention tremor, followed by generalised rigidity and dementia.
(12 Dec 1998)
optic atrophy Atrophy of the optic disk resulting from degeneration of the nerve fibres of the optic nerve and optic tract.
(12 Dec 1998)
optic atrophy, hereditary An inherited disorder in which optic atrophy is associated with muscle weakness, peroneal muscular atrophy and, in some patients, lancinating pains. In these patients the peripheral sensory neurons are probably affected.
(12 Dec 1998)
traction atrophy Bands of thin wrinkled skin, initially red but becoming purple and white, which occur commonly on the abdomen, buttocks, and thighs at puberty and/or during and following pregnancy, and result from atrophy of the dermis and overextension of the skin; also associated with ascites and Cushing's syndrome.
Synonym: atrophoderma striatum, lineae albicantes, lineae atrophicae, linear atrophy, stretch marks, stria, striae atrophicae, striate atrophy of skin, traction atrophy, vergeture.
(05 Mar 2000)
transneuronal atrophy An atrophy of nerve cells following damage to the axons that make synaptic connection with them; noted especially in the lateral geniculate body.
Synonym: transneuronal atrophy, transsynaptic chromatolysis.
(05 Mar 2000)
Erb atrophy A form of progressive muscular atrophy in which the disease begins in the muscle and not in the spinal centres.
Synonym: Erb atrophy, idiopathic muscular atrophy.
(05 Mar 2000)
trophoneurotic atrophy Abnormalities of the skin, hair, nails, subcutaneous tissues and bone, caused by peripheral nerve lesions.
Synonym: neuritic atrophy, neurogenic atrophy, neurotrophic atrophy, trophic changes.
(05 Mar 2000)
essential progressive atrophy of iris Progressive atrophy of the iris without inflammatory signs, characterised by patchy loss of all layers of the iris with hole formation, migration of the pupil, degeneration of the corneal endothelium, peripheral anterior synechiae, and secondary glaucoma; usually unilateral, predominantly affecting women in their middle years.
(05 Mar 2000)
exhaustion atrophy Atrophy, especially of glandular cells, believed to result from excessive functional activity or overstimulation.
(05 Mar 2000)
juvenile muscular atrophy Slowly progressive proximal muscular weakness and wasting, beginning in childhood, caused by degeneration of motor neurons in the anterior horns of the spinal cord; onset usually between 2 and 17 years of age; usually autosomal recessive inheritance.
Synonym: juvenile muscular atrophy, Kugelberg-Welander disease, Wohlfart-Kugelberg-Welander disease.
(05 Mar 2000)
juvenile spinal muscular atrophy Slowly progressive proximal muscular weakness and wasting, beginning in childhood, caused by degeneration of motor neurons in the anterior horns of the spinal cord; onset usually between 2 and 17 years of age; usually autosomal recessive inheritance.
Synonym: juvenile muscular atrophy, Kugelberg-Welander disease, Wohlfart-Kugelberg-Welander disease.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á